Search Results

Filter
  • 1-10 of  4,775 results for ""Deoxycytidine""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Improved Antitumor Efficiency of N 4 -Tetradecyloxycarbonyl Gemcitabine-Loaded Liposomes for Pancreatic Cancer Chemotherapy.

  • Authors : Wang D; Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100050, People's Republic of China.; Wang X

Subjects: Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/analogs & derivatives ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/chemistry ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/pharmacology

  • Source: International journal of nanomedicine [Int J Nanomedicine] 2024 Dec 11; Vol. 19, pp. 13391-13410. Date of Electronic Publication: 2024 Dec 11 (Print Publication: 2024).Publisher: DOVE Medical Press Country of Publication: New Zealand NLM ID: 101263847 Publication Model: eCollection Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Hand therapy interventions for the prevention of chemotherapy-induced peripheral neuropathy of the hands in patients with pancreatic cancer.

  • Authors : Jameson GS; HonorHealth Research Institute, Scottsdale, AZ, United States.; Cooper C

Subjects: Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/analogs & derivatives ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/adverse effects ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/therapeutic use

  • Source: The oncologist [Oncologist] 2024 Dec 06; Vol. 29 (12), pp. 1095-e1778.Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Chemotherapy and radiotherapy for advanced pancreatic cancer.

  • Authors : Haggstrom L; Medical Oncology, The Kinghorn Cancer Care Centre, St Vincent's Hospital, Sydney, Australia.; Medical Oncology, Illawarra Shoalhaven Local Health District, Wollongong, Australia.

Subjects: Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/therapeutic use ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/analogs & derivatives ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/therapeutic use

  • Source: The Cochrane database of systematic reviews [Cochrane Database Syst Rev] 2024 Dec 05; Vol. 12. Cochrane AN: CD011044. Date of Electronic Publication: 2024 Dec 05.Publisher: Wiley Country of Publication: England NLM ID: 100909747 Publication Model: Electronic Cited Medium: Internet ISSN: 1469-493X

Record details

×
Academic Journal

Efficacy and Safety of the Anti-IL1RAP Antibody Nadunolimab (CAN04) in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Advanced/Metastatic Pancreatic Cancer.

Subjects: Paclitaxel*/Paclitaxel*/Paclitaxel*/administration & dosage ; Paclitaxel*/Paclitaxel*/Paclitaxel*/adverse effects ; Gemcitabine*

  • Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Dec 02; Vol. 30 (23), pp. 5293-5303.Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

A Mesoporous Silica-Based Nano-Drug Co-Delivery System with Gemcitabine for Targeted Therapy of Pancreatic Cancer.

  • Authors : Lin Q; Department of Hepatobiliary Surgery, Wenzhou Central Hospital, The Dingli Clinical Institute of Wenzhou Medical University, Wenzhou, Zhejiang, China.; Guan S

Subjects: Gemcitabine* ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/analogs & derivatives ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/administration & dosage

  • Source: Journal of the College of Physicians and Surgeons--Pakistan : JCPSP [J Coll Physicians Surg Pak] 2024 Dec; Vol. 34 (12), pp. 1456-1463.Publisher: College of Physicians and Surgeons Pakistan Country of Publication: Pakistan NLM ID: 9606447 Publication Model: Print Cited Medium: Internet

Record details

×
Academic Journal

Pyrvinium Pamoate Alone and With Gemcitabine Exhibits Anti-Pancreatic Cancer Activity in 2D and 3D Cell Culture Models.

  • Authors : Serala K; Department of Human Biology, University of Cape Town, Observatory, Cape Town, South Africa.; Bai J

Subjects: Pancreatic Neoplasms*/Pancreatic Neoplasms*/Pancreatic Neoplasms*/drug therapy ; Pancreatic Neoplasms*/Pancreatic Neoplasms*/Pancreatic Neoplasms*/pathology ; Gemcitabine*

  • Source: Journal of cellular and molecular medicine [J Cell Mol Med] 2024 Dec; Vol. 28 (23), pp. e70222.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101083777 Publication Model: Print Cited Medium: Internet ISSN: 1582-4934

Record details

×
Academic Journal

Epigenetic Activation of the CMTM6-IGF2BP1-EP300 Positive Feedback Loop Drives Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma.

  • Authors : Zhu YQ; Department of Pancreato-Biliary Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, 510080, China.; Huang Y

Subjects: Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/analogs & derivatives ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/pharmacology ; Gemcitabine*

  • Source: Advanced science (Weinheim, Baden-Wurttemberg, Germany) [Adv Sci (Weinh)] 2024 Dec; Vol. 11 (47), pp. e2406714. Date of Electronic Publication: 2024 Nov 03.Publisher: WILEY-VCH Country of Publication: Germany NLM ID: 101664569 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2198-3844

Record details

×
Academic Journal

Nrf2-mediated adenylosuccinate lyase promotes resistance to gemcitabine in pancreatic ductal adenocarcinoma cells through ferroptosis escape.

  • Authors : Hsu TW; Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei, Taiwan.; Department of Surgery, Division of General Surgery, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan.

Subjects: Gemcitabine* ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/analogs & derivatives ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/pharmacology

  • Source: Journal of cellular physiology [J Cell Physiol] 2024 Dec; Vol. 239 (12), pp. e31416. Date of Electronic Publication: 2024 Aug 20.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0050222 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Exploring epigenetic dynamics unveils a super-enhancer-mediated NDRG1-β-catenin axis in modulating gemcitabine resistance in pancreatic cancer.

  • Authors : Wei D; State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200032, China.; Yuan L

Subjects: Gemcitabine* ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/analogs & derivatives ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/pharmacology

  • Source: Cancer letters [Cancer Lett] 2024 Nov 28; Vol. 605, pp. 217284. Date of Electronic Publication: 2024 Oct 02.Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Spatial interactions of immune cells as potential predictors to efficacy of toripalimab plus chemotherapy in locally advanced or metastatic pancreatic ductal adenocarcinoma: a phase Ib/II trial.

  • Authors : Cheng K; Division of Abdominal Tumor, Department of Medical Oncology, Cancer Center and State Key Laboratory of Biological Therapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China.; Li X

Subjects: Carcinoma, Pancreatic Ductal*/Carcinoma, Pancreatic Ductal*/Carcinoma, Pancreatic Ductal*/drug therapy ; Carcinoma, Pancreatic Ductal*/Carcinoma, Pancreatic Ductal*/Carcinoma, Pancreatic Ductal*/immunology ; Carcinoma, Pancreatic Ductal*/Carcinoma, Pancreatic Ductal*/Carcinoma, Pancreatic Ductal*/pathology

  • Source: Signal transduction and targeted therapy [Signal Transduct Target Ther] 2024 Nov 25; Vol. 9 (1), pp. 321. Date of Electronic Publication: 2024 Nov 25.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101676423 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  4,775 results for ""Deoxycytidine""